A sophisticated private equity buyer is using a regression-based model to analyze our historical financial data. What diagnostic checks are they running on our trailing twelve months EBITDA, and how do we prepare?

Question

Tyler Smith · Accepted Answer

Sophisticated private equity buyers will perform rigorous diagnostic checks on your trailing twelve months EBITDA to ensure your financial reporting is robust and compliant with standard accounting principles. They are looking for stability, predictability, and any potential red flags, such as revenue recognition inconsistencies or abnormal working capital swings. To prepare for this level of scrutiny, your finance department must have clean, audit-ready financial statements. You must be ready to prove that your EBITDA is normalized, meaning all nonrecurring expenses, owner compensation adjustments, and personal expenses have been clearly identified and backed out. Buyers will also check for multicollinearity and volatility in your revenue streams to assess the risk of your future cash flows. To mitigate these concerns, you should demonstrate a disciplined financial process within your weekly operations. Show how your scorecard metrics and financial key performance indicators are tracked and reviewed regularly by your leadership team. By preparing your financial data with the same level of discipline you use to run your EOS® meetings, you can confidently address the buyer's diagnostic checks and defend your enterprise value.